SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 179 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $117,345 | -23.3% | 90,265 | +3.8% | 0.02% | -25.9% |
Q1 2023 | $153,004 | -28.2% | 86,934 | +28.0% | 0.03% | -27.0% |
Q4 2022 | $213,237 | -13.7% | 67,910 | +34.8% | 0.04% | -21.3% |
Q3 2022 | $247,000 | +72.7% | 50,365 | +45.3% | 0.05% | +88.0% |
Q2 2022 | $143,000 | – | 34,661 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |